NAD+ may influence several processes tied to metabolism, but there is not enough human evidence to say that NAD+ reliably causes weight loss. Small trials of NAD+ precursors such as NMN and NR have produced mixed results. One NMN study found a modest drop in body weight, while other trials found changes in metabolism or insulin sensitivity without meaningful fat loss. (1)(2)(3)

There is another wrinkle here. NAD+, NMN, NR, and NAD injections are related, but they are not the same thing. Much of the human research people cite for "NAD weight loss" has studied oral NMN or NR rather than injected NAD+.

Key Takeaways:

• NAD+ helps cells process energy, but that does not mean raising NAD+ automatically burns body fat.

• One small NMN trial found a 1.9 kg greater reduction in body weight compared with placebo after 28 days. (1)

• Other NMN and NR studies found little or no change in body fat, weight, or fat oxidation. (2)(3)

• Direct evidence for NAD injections as a weight-loss treatment remains very limited.

Does NAD Help With Weight Loss?

Right now, there is not enough evidence to say NAD+ supplements or injections lead to reliable weight loss in humans.

The idea is not pulled out of thin air. NAD+, short for nicotinamide adenine dinucleotide, helps your cells convert nutrients into usable energy. It also participates in pathways linked with mitochondrial function, glucose metabolism, and cellular signaling.

Still, there is an important line between those roles and losing weight.

Your cells can become better at handling certain metabolic tasks without your body burning enough extra energy to noticeably change the number on the scale. Human trials give us a good example of that distinction.

What Does the Research Say About NAD and Weight Loss?

Human research is still small, but we have enough data to see that the story is more complicated than "more NAD equals more fat burning."

One of the more interesting studies involved 30 adults aged 45 or older who were overweight or obese. Participants received either placebo or 2,000 mg of NMN per day for 28 days.

By the end of the trial, body weight had fallen significantly more in the NMN group, with a 1.9 kg difference between NMN and placebo. However, researchers did not find significant differences in liver fat or intra-abdominal fat. (1)

That last part matters. Weight moved, but measurable fat in two important areas did not.

Another trial studied 25 postmenopausal women with prediabetes who were overweight or obese. After 10 weeks of 250 mg of NMN per day, muscle insulin sensitivity improved by about 25% compared with baseline. Yet fat mass, intra-abdominal fat, liver fat, blood pressure, glucose, and several other metabolic measures did not significantly change. (2)

NR, another NAD+ precursor, has produced similarly mixed findings.

In one randomized trial involving 40 men with obesity, participants took 2,000 mg of NR per day for 12 weeks. Researchers did not find improvements in insulin sensitivity, glucose metabolism, body composition, or the body's ability to mobilize and oxidize fat. (3)

A smaller study involving 13 adults who were overweight or obese produced a slightly different result. Six weeks of 1,000 mg NR per day increased sleeping metabolic rate and slightly increased the proportion of fat-free mass. 

Even so, researchers found no improvement in insulin sensitivity, mitochondrial function, liver fat, muscle fat, or several other measures of metabolic health. (4)

Here's how those results line up:

The larger picture is becoming clearer too. A 2026 systematic review and meta-analysis examined 15 NMN trials using doses from 250 to 2,000 mg per day for periods ranging from 14 days to 24 weeks. Across the available trials, researchers found no significant effect on body weight or BMI. (5)

So, one small study produced an encouraging weight signal, but the wider evidence does not yet show a consistent weight-loss effect.

How Could NAD+ Be Connected to Metabolism?

NAD+ sits near the center of many reactions involved in turning food into cellular energy.

Among other roles, it is involved in:

• Breaking down carbohydrates and fats for energy

• Mitochondrial energy production

• Maintaining the balance between NAD+ and NADH

• Cellular signaling

• Enzymes such as sirtuins that respond to the cell's energy state

This explains why researchers are interested in NAD+ when studying obesity and metabolic health. But there is a trap here.

"Supports energy metabolism" sounds a lot like "increases calorie burning" when you read it quickly. Biologically, those are very different claims.

For weight to fall over time, the body still needs to use more energy than it takes in. Improving one cellular pathway does not automatically create a meaningful calorie deficit.

That may explain why some NAD precursor studies detect changes in insulin signaling or metabolic rate while body fat barely moves.

Do NAD Injections Help With Weight Loss?

There is currently little controlled human evidence showing that NAD injections alone cause meaningful weight loss.

This gets lost in a lot of online discussions because "NAD weight loss" can refer to several different treatments.

Most of the human trials discussed above used oral NMN or NR, which the body can use to make NAD+. They did not inject NAD+ directly.

NAD injections and IV infusions bypass the digestive system, but that does not mean they have been proven to burn more fat or produce greater weight loss. Direct trials testing injected NAD+ specifically for obesity are lacking.

Some clinics also offer NAD alongside diet programs, exercise plans, vitamin injections, or prescription weight-loss medications. If someone loses weight while using several of these at once, we cannot assume NAD caused the change.

There is a related point worth knowing if NAD appears in compounded weight-loss injections. The FDA has noted that some compounders add ingredients such as NAD to semaglutide products. The agency states that the safety and effectiveness of combining semaglutide with added ingredients have not been established. (6)

That does not mean every NAD injection is unsafe. It means the evidence behind compounded combinations should not be confused with the clinical evidence behind approved weight-loss medications.

NAD vs NMN vs NR for Weight Loss

These terms get thrown into the same basket, but they describe different compounds.

NMN has produced one of the stronger signals so far, with the 28-day study reporting the 1.9 kg between-group weight difference. (1)

Still, that trial was small and short. Larger analyses have not found a consistent reduction in body weight across NMN trials. (5)

That makes it far too early to call NMN a weight-loss supplement.

Can NAD Help Indirectly With Weight Management?

This is where the discussion gets more interesting. A supplement does not need to directly melt fat to influence factors connected with metabolic health. Researchers are studying NAD+ precursors for possible effects on:

• Insulin sensitivity

• Glucose handling

• Cellular energy production

• Muscle metabolism

• Exercise performance

• Age-related metabolic changes

For example, the 10-week NMN trial in women with prediabetes improved muscle insulin sensitivity despite producing no meaningful change in body fat. (2)

That finding could matter for metabolic health, but it should not be repackaged as a weight-loss result.

Think of it like improving the engine rather than making the car lighter. The two may relate, but one does not guarantee the other.

Diet, physical activity, sleep, calorie intake, medications, genetics, and health conditions still play much larger roles in body-weight regulation.

Is NAD a Weight-Loss Drug?

No. NAD+, NMN, and NR are not established weight-loss medications.

They are being studied for cellular metabolism, healthy aging, and related areas, but the evidence base is very different from medications developed and tested specifically for obesity.

That distinction matters if you see NAD injections marketed alongside drugs such as semaglutide.

Weight-loss medications have clinical trials that directly measure changes in body weight across larger groups and longer periods. NAD research has mostly focused on NAD levels, metabolic markers, muscle function, insulin sensitivity, and safety.

Those are useful questions. They are just not the same question as "How much weight will this make me lose?"

Final Words

NAD+ certainly has a relationship with metabolism. The leap from that fact to "NAD causes weight loss," though, is still much bigger than current human research can support.

One small NMN trial found a 1.9 kg greater drop in weight than placebo after four weeks, which makes the topic worth studying further. (1) 

Yet other controlled trials found no meaningful changes in fat mass, body composition, or fat oxidation, and a recent analysis of 15 NMN trials found no significant effect on body weight. (2)(3)(5)

For now, NAD+ precursors make more sense to discuss in the context of cellular health and healthy aging, rather than as fat-loss products.

If supporting NAD+ production is part of your healthy-aging routine, Omre NMN + Resveratrol combines 500 mg of high-purity NMN with 500 mg of micronized resveratrol in a formula designed around cellular health and sustained daily energy. 

It is not a shortcut for weight loss, and frankly, that is not what it is designed to be.

FAQs

Does NAD burn belly fat?

There is no good human evidence showing that NAD+ specifically burns belly fat. One short NMN trial found lower body weight but no significant reduction in intra-abdominal fat after 28 days. (1)

How much weight can you lose with NAD?

There is no established amount. A small NMN trial found a 1.9 kg greater reduction in weight compared with placebo after 28 days, but larger evidence does not show consistent weight loss from NMN supplementation. (1)(5)

Do NAD injections reduce appetite?

There is not strong clinical evidence showing that NAD injections directly suppress appetite. Claims about appetite reduction should not be treated the same as evidence for medications specifically studied for obesity.

Is NMN better than NAD for weight loss?

We cannot say that NMN is better for weight loss. NMN has more human research related to metabolic health than direct NAD injections, but studies have not shown consistent reductions in body weight or body fat. (1)(2)(5)

Can I take NAD supplements while trying to lose weight?

NAD+ precursors may be used as part of a broader wellness routine, but they should not replace a calorie-controlled diet, physical activity, medical care, or evidence-based obesity treatment. If you take medications or have a health condition, talk with your healthcare provider before adding a new supplement.

References

1. Pencina, K. M., et al. (2024). Nicotinamide adenine dinucleotide augmentation in overweight or obese middle-aged and older adults: A physiologic study. The Journal of Clinical Endocrinology & Metabolism.

2. Yoshino, M., Yoshino, J., Kayser, B. D., Patti, G. J., Franczyk, M. P., Mills, K. F., Sindelar, M., Pietka, T., Patterson, B. W., Imai, S. I., & Klein, S. (2021). Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science, 372(6547), 1224–1229.

3. Dollerup, O. L., Christensen, B., Svart, M., Schmidt, M. S., Sulek, K., Ringgaard, S., Stødkilde-Jørgensen, H., Møller, N., Brenner, C., Treebak, J. T., & Jessen, N. (2018). A randomized placebo-controlled clinical trial of nicotinamide riboside in obese men: Safety, insulin-sensitivity, and lipid-mobilizing effects. The American Journal of Clinical Nutrition, 108(2), 343–353.

4. Remie, C. M. E., Roumans, K. H. M., Moonen, M. P. B., Connell, N. J., Havekes, B., Mevenkamp, J., Lindeboom, L., de Wit, V. H. W., van de Weijer, T., Aarts, S. A. B. M., Lutgens, E., Schomakers, B. V., Elfrink, H. L., Zapata-Pérez, R., Houtkooper, R. H., Auwerx, J., Hoeks, J., Schrauwen-Hinderling, V. B., Phielix, E., & Schrauwen, P. (2020). Nicotinamide riboside supplementation alters body composition and skeletal muscle acetylcarnitine concentrations in healthy obese humans. The American Journal of Clinical Nutrition, 112(2), 413–426.

5. Safety and metabolism-related outcomes of oral nicotinamide mononucleotide supplementation in adults: A systematic review and meta-analysis. (2026).

6. U.S. Food and Drug Administration. (n.d.). FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products. U.S. Food and Drug Administration.